Scott Farquhar Sells 7,665 Shares of Atlassian (NASDAQ:TEAM) Stock

Atlassian Corporation PLC (NASDAQ:TEAM) Director Scott Farquhar sold 7,665 shares of the business’s stock in a transaction that occurred on Thursday, November 13th. The stock was sold at an average price of $153.77, for a total transaction of $1,178,647.05. Following the sale, the director directly owned 245,280 shares of the company’s stock, valued at approximately $37,716,705.60. This trade represents a 3.03% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Scott Farquhar also recently made the following trade(s):

• On Monday, November 10th, Scott Farquhar sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $158.00, for a total transaction of $1,211,070.00.
• On Friday, November 7th, Scott Farquhar sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $155.58, for a total value of $1,192,520.70.
• On Wednesday, November 5th, Scott Farquhar sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $162.66, for a total value of $1,246,788.90.
• On Monday, November 3rd, Scott Farquhar sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $172.79, for a total value of $1,324,435.35.
• On Friday, October 31st, Scott Farquhar sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $167.61, for a total value of $1,284,730.65.
• On Wednesday, October 29th, Scott Farquhar sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $160.41, for a total value of $1,229,542.65.
• On Monday, October 27th, Scott Farquhar sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $165.03, for a total value of $1,264,954.95.
• On Friday, October 24th, Scott Farquhar sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $164.50, for a total transaction of $1,260,892.50.
• On Wednesday, October 22nd, Scott Farquhar sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $169.16, for a total transaction of $1,296,611.40.
• On Friday, October 17th, Scott Farquhar sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $151.21, for a total transaction of $1,159,024.65.

Atlassian Trading Down 0.2%

TEAM opened at $151.79 on Friday. The firm’s fifty day moving average is $161.52 and its two-hundred day moving average is $184.15. The firm has a market cap of $39.94 billion, a PE ratio of -213.79, a price-to-earnings-growth ratio of 36.00 and a beta of 0.95. Atlassian Corporation PLC has a twelve month low of $144.32 and a twelve month high of $326.00. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.26 and a current ratio of 1.26.

Atlassian (NASDAQ:TEAM) last announced its quarterly earnings results on Thursday, October 30th. The technology company reported $1.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.83 by $0.21. The company had revenue of $1.43 billion during the quarter, compared to analyst estimates of $1.40 billion. Atlassian had a negative net margin of 3.38% and a negative return on equity of 7.11%. The firm’s revenue was up 20.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.77 EPS. Atlassian has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. Equities research analysts anticipate that Atlassian Corporation PLC will post -0.34 EPS for the current year.

Institutional Investors Weigh In On Atlassian

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Capco Asset Management LLC acquired a new stake in shares of Atlassian in the second quarter valued at about $25,000. Physician Wealth Advisors Inc. grew its stake in Atlassian by 60.4% in the third quarter. Physician Wealth Advisors Inc. now owns 162 shares of the technology company’s stock valued at $26,000 after purchasing an additional 61 shares in the last quarter. Smithfield Trust Co increased its position in shares of Atlassian by 90.7% during the 1st quarter. Smithfield Trust Co now owns 164 shares of the technology company’s stock worth $34,000 after purchasing an additional 78 shares during the last quarter. Geneos Wealth Management Inc. raised its stake in shares of Atlassian by 447.2% during the 1st quarter. Geneos Wealth Management Inc. now owns 197 shares of the technology company’s stock worth $42,000 after purchasing an additional 161 shares in the last quarter. Finally, Atlantic Union Bankshares Corp boosted its holdings in shares of Atlassian by 19,900.0% in the 3rd quarter. Atlantic Union Bankshares Corp now owns 200 shares of the technology company’s stock valued at $32,000 after buying an additional 199 shares during the last quarter. 94.45% of the stock is owned by institutional investors.

Analysts Set New Price Targets

TEAM has been the topic of several recent analyst reports. Robert W. Baird set a $230.00 price objective on Atlassian in a report on Friday, October 31st. Oppenheimer dropped their target price on shares of Atlassian from $300.00 to $275.00 and set an “outperform” rating on the stock in a report on Monday, July 21st. Wells Fargo & Company assumed coverage on shares of Atlassian in a report on Tuesday, September 30th. They issued an “overweight” rating and a $216.00 price target for the company. Citigroup restated a “buy” rating on shares of Atlassian in a report on Wednesday, October 22nd. Finally, Sanford C. Bernstein cut their price objective on shares of Atlassian from $296.00 to $290.00 and set an “outperform” rating on the stock in a research report on Friday, October 31st. One investment analyst has rated the stock with a Strong Buy rating, twenty have assigned a Buy rating, nine have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $239.44.

About Atlassian

Atlassian Corporation, through its subsidiaries, designs, develops, licenses, and maintains various software products worldwide. Its product portfolio includes Jira Software and Jira Work Management, a project management system that connects technical and business teams so they can better plan, organize, track and manage their work and projects; Confluence, a connected workspace that organizes knowledge across all teams to move work forward; and Trello, a collaboration and organization product that captures and adds structure to fluid and fast-forming work for teams.